Omar Oakes
May 8, 2018

GSK reviews global media

Pharma giant GlaxoSmithKline has reportedly launched a review of its US $1.8 billion global media agency arrangements, putting MediaCom and PHD on alert.

GSK reviews global media

The review, which is being handled by ID Comms, comes less than three years after GSK awarded its European business to MediaCom, while PHD was handed its US media account.

Both agencies had retained the accounts in 2015 following a global media review, after having been first appointed in 2013.

A year later, GSK completed an agency review for the other parts of its marketing comms business by hiring nine agencies, including Grey and Saatchi & Saatchi for advertising.

GSK's agencies were appointed to work on the company's seven power brands (Sensodyne, Parodontax, Poligrip, Voltaren, Panadol, Theraflu and Otrivin) and 12 core brands (Biotene, Contac, Flonase, Excedrin, Fenbid, Tums, ENO, Horlicks, Physiogel, Lamisil, Fenistil and Abreva/Zovirax).

GSK did not respond to a request for comment by Campaign UK by press time while MediaCom and PHD would not comment and referred Campaign to GSK.

Source:
Campaign UK

Related Articles

Just Published

4 hours ago

As Omicron rages, Singapore's MCI and Grey promote ...

Increasingly frustrated grand parents realise the futility of trying to host a large family group, with the pandemic far from being extinguished.

4 hours ago

M&C Saatchi rejects improved bid from AdvancedAdvT

Vin Murria wants to add two board directors, including COO.

13 hours ago

Should brands continue to take a stance in Asia's ...

After Samsung pulled an ad featuring a drag queen and his mother in Singapore, eight creative and communications leaders discuss how brands should balance purpose and politics.

14 hours ago

Women Leading Change Awards 2022: Call for entries

Get started now on your entries for the sixth-annual awards honouring business leaders, change-makers, trailblazers, and rising stars. The early-bird deadline is February 25.